I agree with PNW There will be reverse split. Nader can’t deal with a messed up reverse split. Nader knows he would lose his Role as the ceo and he won’t risk it with the company being so derisked over the past 120 days. Baer wants a very big paycheck.
Nader is very smart and highly strategic. He removed the reverse split to help remove the pressure cooker role he’s in.... he no longer needs a reverse split. There is so value that has been created. I estimate they have at least $3B as a figure ray could work.... $6-$8 a share
Look if a company is in phase 1 and phase 2 like ADXS, RXII, LJPC were then I don't recommend a reverse stock split. What I'm saying is that CYDY is close to a BLA filing. if it coordinates a reverse stock split a few days before the BLA filing it will have established buyers buying up stock. It won't tank. The biotech you are describing is nowhere close yet to filing a BLA or NDA. Does that make sense?